Litcius/Paper detail

AI-enabled in silico immunohistochemical characterization for Alzheimer's disease

Bryan He, Syed Bukhari, Edward Fox, Abubakar Abid, Jeanne Shen, Claudia H. Kawas, María M. Corrada, Thomas J. Montine, James Zou

2022Cell Reports Methods26 citationsDOIOpen Access PDF

Abstract

We develop a deep learning approach, in silico immunohistochemistry (IHC), which takes routinely collected histochemical-stained samples as input and computationally generates virtual IHC slide images. We apply in silico IHC to Alzheimer's disease samples, where several hallmark changes are conventionally identified using IHC staining across many regions of the brain. In silico IHC computationally identifies neurofibrillary tangles, β-amyloid plaques, and neuritic plaques at a high spatial resolution directly from the histochemical images, with areas under the receiver operating characteristic curve of between 0.88 and 0.92. In silico IHC learns to identify subtle cellular morphologies associated with these lesions and can generate in silico IHC slides that capture key features of the actual IHC.

Topics & Concepts

In silicoImmunohistochemistryPathologyAmyloid (mycology)BiologyComputational biologyComputer scienceMedicineGeneticsGeneAI in cancer detectionCell Image Analysis TechniquesDigital Imaging for Blood Diseases
AI-enabled in silico immunohistochemical characterization for Alzheimer's disease | Litcius